The great mimicker: IgG4-related disease

Clinical Rheumatology

Volumn 32, Issue 9, 2013, Pages 1267-1273

  Perez Alamino, Rodolfo ^a   Espinoza, Luis R ^a   Zea, Arnold H ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmune pancreatitis; Corticosteroids; IgG4; IgG4 related disease; Rituximab; Vasculitis

Indexed keywords

GLUCOCORTICOID; HLA DQB1 ANTIGEN; HLA DRB1 ANTIGEN; IMMUNOGLOBULIN G4; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; PREDNISOLONE; PREDNISONE; RITUXIMAB;

AUTOIMMUNITY; CLINICAL FEATURE; DACRYOCYSTITIS; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; HELICOBACTER INFECTION; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL NEPHRITIS; KUTTNER TUMOR; LIVER DISEASE; MIKULICZ DISEASE; PANCREATITIS; PAROTITIS; PATHOGENESIS; PRIORITY JOURNAL; REMISSION; RETROPERITONEAL FIBROSIS; REVIEW; RIEDEL THYROIDITIS; SALIVARY GLAND TUMOR; SCLEROSING CHOLANGITIS; SIALOADENITIS; TH1 TH2 BALANCE; THYROIDITIS; TREATMENT DURATION;

ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOIMMUNE DISEASES; CYTOKINES; DIAGNOSIS, DIFFERENTIAL; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; REMISSION INDUCTION; TREATMENT OUTCOME; VASCULITIS;

EID: 84883245212     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2326-z     Document Type: Review

References (61)

1. Hamano H, Kawa S, Horiuchi A et al (2001) High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 344:732-738
2. Umehara H, Okazaki K, Masaki Y, Research Program for Intractable Disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 Team et al (2012) A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol 22:1-14
3. Nirula A, Glaser SM, Kalled SL et al (2011) What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 23:119-124
4. Aalberse RC, Schuurman J (2002) IgG4 breaking the rules. Immunology 105:9-19
5. Rispens T, Ooijevaar-de Heer P, Bende O et al (2011) Mechanism of immunoglobulin G4 Fab-arm exchange. J Am Chem Soc 133:10302-10311
6. Zen Y, Nakanuma Y (2011) Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 23:114-118
7. Kawa S, Ota M, Yoshizawa K et al (2002) HLA DRB1 0405-DQB1 0401 haplotype is associated with autoimmune pancreatitis in the Japanese population. Gastroenterology 122:1264-1269
8. Park DH, Kim M, Oh H et al (2008) Substitution of aspartic acid at position 57 of the DQ beta1 affects relapse of autoimmune pancreatitis. Gastroenterology 134:440-446
9. Chang MC, Chang YT, Tien YW et al (2007) T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis. Clin Chem 53:1700-1705
10. Umemura T, Ota M, Hamano H et al (2008) Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients. Am J Gastroenterol 103:588-594
11. Umemura T, Ota M, Hamano H et al (2006) Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients. Gut 55:1367-1368
12. Nishimori I, Miyaji E, Morimoto K et al (2005) Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis. Gut 54:274-281
13. Löhr JM, Faissner R, Koczan D et al (2010) Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol 105:2060-2071
14. Asada M, Nishio A, Uchida K et al (2006) Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis. Pancreas 33:20-26
15. Yamamoto M, Naishiro Y, Suzuki C et al (2010) Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome. Rheumatol Int 30:565-568
16. Frulloni L, Lunardi C, Simone R et al (2009) Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 361:2135-2142
17. Guarneri F, Guarneri C, Benvenga S (2005) Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry? J Cell Mol Med 9:741-744
18. Akitake R, Watanabe T, Zaima C et al (2010) Possible involvement of T-helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 59:542-545
19. Kanari H, Kagami S, Kashiwakuma D et al (2010) Role of Th2 cells in IgG4-related lacrimal gland enlargement. Int Arch Allergy Immunol 152(Suppl 1):47-53
20. Suzuki K, Tamaru J, Okuyama A et al (2010) IgG4-positive multi-organ lymphoproliferative syndrome manifesting as chronic symmetrical sclerosing dacryo-sialadenitis with subsequent secondary portal hypertension and remarkable IgG4-linked IL-4 elevation. Rheumatology (Oxford) 49:1789-1791
21. Kamisawa T, Anjiki H, Egawa N et al (2009) Allergic manifestations in autoimmune pancreatitis. Eur J Gastroenterol Hepatol 21:1136-1139
22. +CD25 high regulatory cells in patients with autoimmune pancreatitis. Pancreas 36:133-140
23. Detlefsen S, Sipos B, Zhao J et al (2008) Autoimmune pancreatitis: expression and cellular source of profibrotic cytokines and their receptors. Am J Surg Pathol 32:986-995
24. Kamisawa T, Egawa N, Nakajima H (2003) Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 98:2811-2812
25. Stone J, Khosroshahi A, Deshpande V et al (2012) Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations. Arthritis Rheum 64:3061-3067
26. Kamisawa T, Takuma K, Egawa N et al (2010) Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 7:401-409
27. Stone J, Khosroshahi A, Hilgenberg A et al (2009) IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum 60:3139-3145
28. Stone J, Caruso P, Deshpande V (2009) Case records of the Massachusetts General Hospital. Case 24-2009: a 26-year-old woman with painful swelling of the neck. N Engl J Med 361:511-518
29. Stone J, Patel V, Oliveira G et al (2012) Case records of the Massachusetts General Hospital. Case 38-2012: a 60-year-old man with abdominal pain and aortic aneurysms. N Eng J Med 367:2335-2346
30. Khosroshahi A, Stone J (2011) A clinical overview of IgG4-related systemic disease. Curr Opin Rheumatol 23:57-66
31. Zen Y, Nakanuma Y (2010) IgG4-related disease. A cross-sectional study of 114 patients. Am J Surg Pathol 34:1812-1819
32. Stone J, Zen Y, Deshpande V (2012) IgG4-related disease. N Engl J Med 366:539-551
33. Yoshida K, Toki F, Takeuchi T et al (1995) Chronic pancreatitis caused by an autoimmune abnormality: proposal of the concept of autoimmune pancreatitis. Dig Dis Sci 40:1561-1568
34. Sahani D, Kalva S, Farrell J et al (2004) Autoimmune pancreatitis: imaging features. Radiology 233:345-352
35. Ghazale A, Chari S, Zhang L et al (2008) Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 134:706-715
36. Umemura T, Zen Y, Hamano H et al (2007) IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis. Gut 56:1471-1472
37. Geyer J, Ferry J, Harris N et al (2010) Chronic sclerosing sialadenitis (Küttner tumor) is an IgG4-associated disease. Am J Surg Pathol 34:202-210
38. Sato Y, Ohshima K, Ichimura K et al (2008) Ocular adrenal IgG4-related disease has uniform clinicopathology. Pathol Int 58:465-470
39. Espinoza GM (2010) Orbital inflammatory pseudotumors: etiology, differential diagnosis and management. Curr Rheumatol Report 12:443-447
40. Dahlgren M, Khosroshahi A, Nielsen G et al (2010) Riedel's thyroiditis and multifocal fibrosclerosis are part of the IgG4-related systemic disease spectrum. Arthritis Care Res (Hoboken) 62:1312-1318
41. Saeki T, Nishi S, Imai N et al (2010) Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis. Kidney Int 10:1016-1023
42. Cornell L, Chicano S, Deshpande V et al (2007) Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. Am J Surg Pathol 31:1586-1597
43. Stone J (2011) Aortitis, periaortitis and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 23:88-94
44. Stone J, Khosroshahi A, Deshpande V et al (2010) IgG4-related systemic disease accounts for a significant proportion of thoracic lymphoplasmacytic aortitis cases. Arthrit Care Res 62:316-322
45. Zen Y, Onodera M, Inoue D et al (2009) Retroperitoneal fibrosis: a clinicopathologic study with respect to immunoglobulin G4. Am J Surg Pathol 33:1833-1839
46. Yamashita K, Haga H, Kobashi Y et al (2008) Lung involvement in IgG4-related lymphoplasmacytic vasculitis and interstitial fibrosis: report of 3 cases and review of the literature. Am J Surg Pathol 32:1620-1626
47. Zen Y, Inoue D, Kitao A et al (2009) IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 33:1886-1893
48. Sato Y, Kojima M, Takata K et al (2009) Systemic IgG4-related lymphadenopathy: a clinic and pathologic comparison to multicentric Castleman's disease. Mod Pathol 22:589-599
49. Chan S, Cheuk W, Chan K et al (2009) IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol 33:1249-1252
50. Cheuk W, Chan A, Lam W et al (2009) IgG4-related sclerosing mastitis: description of a new member of the IgG4-releted sclerosing diseases. Am J Surg Pathol 33:1058-1064
51. Haraguchi A, Era A, Yasui J et al (2010) Putative IgG4-related pituitary disease with hypopituitarism and/or diabetes insipidus accompanied with elevated serum levels of IgG4. Endocr J 57:719-725
52. Yoshimura Y, Takeda S, Ieki Y et al (2006) IgG4-associated prostatitis complicating autoimmune pancreatitis. Intern Med 45:897-901
53. Takikita-Suzuki M, Ishida M, Okabe H (2010) Re-evaluation of IgG4 in systemic fibroinflammatory disease with intracardiac involvement. Hum Pathol 41:458-459
54. Cheuk W, Lee K, Chong L et al (2009) IgG4-related sclerosing disease. A potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 33:1713-1719
55. Deshpande V, Zen Y, Chan J et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25:1181-1192
56. Khosroshahi A, Cheryk L, Carruthers M et al (2012) Prozone phenomenom leads to low IgG4 concentrations in IgG4-related disease (Abstract 2527). Arthritis Rheum 64(10 Suppl):S1067
57. Khosroshahi A, Stone J (2011) Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol 23:67-71
58. Kamisawa T, Okazaki K, Kawa S et al (2010) Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP. J Gastroenterol 45:471-477
59. Pannala R, Chari S (2009) Corticosteroid treatment for autoimmune pancreatitis. Gut 58:1438-1439
60. Khosroshahi A, Bloch D, Deshpande V et al (2010) Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum 62:1755-1762
61. Khosroshahi A, Carruthers M, Deshpande V et al (2012) Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore) 91:57-66